Sevirumab Antibody
Sevirumab (MSL-109) is a human IgG1 monoclonal antibody that neutralizes cytomegalovirus (CMV) by targeting the viral gH complex, inhibiting replication with an EC50 of 0.3 μg/mL. It has been utilized in both in vitro virology studies and in vivo preclinical models to investigate CMV pathogenesis and therapeutic intervention.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
290119-01 5 mg
1-[1- (2-Thienyl) cyclohexyl]pyrrolidine hydrochloride
Sign In for Pricing
View Details 290119-02 10 mg
1-[1- (2-Thienyl) cyclohexyl]pyrrolidine hydrochloride
Sign In for Pricing
View Details 290119-03 25 mg
1-[1- (2-Thienyl) cyclohexyl]pyrrolidine hydrochloride
Sign In for Pricing
View Details